Navarini, AA;
Hruz, P;
Berger, CT;
Hou, TZ;
Schwab, C;
Gabrysch, A;
Higgins, R;
... Recher, M; + view all
(2016)
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis.
Journal of Allergy and Clinical Immunology
10.1016/j.jaci.2016.08.042.
(In press).
Preview |
Text
Navarini_Vedolizumab as a successful treatment.pdf - Accepted Version Download (4MB) | Preview |
| Type: | Article |
|---|---|
| Title: | Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.jaci.2016.08.042 |
| Publisher version: | http://dx.doi.org/10.1016/j.jaci.2016.08.042 |
| Language: | English |
| Additional information: | Copyright © 2016 American Academy of Allergy, Asthma & Immunology. This manuscript version is made available under the CC-BY-NC-ND 4.0 license (http://creativecommons.org/licenses/by-nc-nd/4.0) |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1534845 |
Archive Staff Only
 |
View Item |
